These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 1353912)

  • 1. Mediation of skin allograft rejection in scid mice by CD4+ and CD8+ T cells.
    Shelton MW; Walp LA; Basler JT; Uchiyama K; Hanto DW
    Transplantation; 1992 Aug; 54(2):278-86. PubMed ID: 1353912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogenous graft rejection pathways in class I major histocompatibility complex-disparate combinations and their differential susceptibility to immunomodulation induced by intravenous presensitization with relevant alloantigens.
    Kitagawa S; Iwata H; Sato S; Shimizu J; Hamaoka T; Fujiwara H
    J Exp Med; 1991 Sep; 174(3):571-81. PubMed ID: 1678775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adoptive immunity in immune-deficient scid/scid mice. I. Differential requirements of naive and primed lymphocytes for CD4+ T cells during rejection of minor histocompatibility antigen-disparate skin grafts.
    Roopenian DC; Anderson PS
    Transplantation; 1988 Dec; 46(6):899-904. PubMed ID: 2905088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular basis of skin allograft rejection across a class I major histocompatibility barrier in mice depleted of CD8+ T cells in vivo.
    Rosenberg AS; Munitz TI; Maniero TG; Singer A
    J Exp Med; 1991 Jun; 173(6):1463-71. PubMed ID: 1674524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type 2 immune deviation has differential effects on alloreactive CD4+ and CD8+ T cells.
    Matesic D; Valujskikh A; Pearlman E; Higgins AW; Gilliam AC; Heeger PS
    J Immunol; 1998 Nov; 161(10):5236-44. PubMed ID: 9820495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute rejection of cardiac allografts by noncytolytic CD4(+) T cell populations.
    VanBuskirk AM; Wakely ME; Orosz CG
    Transplantation; 1996 Jul; 62(2):300-2. PubMed ID: 8755833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4-positive helper T lymphocytes mediate mouse cardiac allograft rejection independent of donor alloantigen specific cytotoxic T lymphocytes.
    Bishop DK; Chan S; Li W; Ensley RD; Xu S; Eichwald EJ
    Transplantation; 1993 Oct; 56(4):892-7. PubMed ID: 8212213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity of CD4+ T cells involved in anti-allo-class I H-2 immune responses. Functional discrimination between the major proliferating cells and helper cells assisting cytotoxic T cell responses.
    Kitagawa S; Sato S; Azuma T; Shimizu J; Hamaoka T; Fujiwara H
    J Immunol; 1991 Apr; 146(8):2513-21. PubMed ID: 1673140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor allograft rejection is mainly mediated by CD8+ cytotoxic T lymphocytes stimulated with class I alloantigens in cooperation with CD4+ helper T cells recognizing class II alloantigens.
    Tomita Y; Mayumi H; Eto M; Nomoto K
    J Immunol; 1990 Mar; 144(6):2425-35. PubMed ID: 1968930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mobilization of T lymphocytes following cardiac transplantation. Evidence that CD4-positive cells are required for cytotoxic T lymphocyte activation, inflammatory endothelial development, graft infiltration, and acute allograft rejection.
    Bishop DK; Shelby J; Eichwald EJ
    Transplantation; 1992 Apr; 53(4):849-57. PubMed ID: 1533070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of antiskin allograft immunity induced by infusions with photoinactivated effector T lymphocytes (PET cells). Is in vivo cell transferrable?
    Perez M; Lobo FM; Yamane Y; John L; Berger CL; Edelson RL
    Ann N Y Acad Sci; 1991 Dec; 636():95-112. PubMed ID: 1793234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell subsets required for in vivo and in vitro responses to single and multiple minor histocompatibility antigens.
    Wettstein PJ; Korngold R
    Transplantation; 1992 Aug; 54(2):296-307. PubMed ID: 1353915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4-CD8- T cell receptor alpha beta T cells: generation of an in vitro major histocompatibility complex class I specific cytotoxic T lymphocyte response and allogeneic tumor rejection.
    Mieno M; Suto R; Obata Y; Udono H; Takahashi T; Shiku H; Nakayama E
    J Exp Med; 1991 Jul; 174(1):193-201. PubMed ID: 1905338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adoptive transfer of a Th2-like cell line prolongs MHC class II antigen disparate skin allograft survival in the mouse.
    Maeda H; Takata M; Takahashi S; Ogoshi S; Fujimoto S
    Int Immunol; 1994 Jun; 6(6):855-62. PubMed ID: 8086373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The lymphoid cell populations required for induction of tolerance of different subsets of alloantigen-reactive T cells.
    Sato S; Iwata H; Kitagawa S; Kokudo S; Okuno K; Hamaoka T; Fujiwara H
    Transplantation; 1991 Nov; 52(5):862-7. PubMed ID: 1835197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Xenogeneic iso-skin graft and mixed lymphocyte reaction studies using HLA-DP transgenic mice.
    Hagihara M; Shimura T; Takebe K; Munkhbat B; Sato T; Tsuchida F; Sato K; Tsuji K
    Transpl Immunol; 1996 Sep; 4(3):220-6. PubMed ID: 8893453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rejection responses to allogeneic hepatocytes by reconstituted SCID mice, CD4, KO, and CD8 KO mice.
    Bumgardner GL; Gao D; Li J; Baskin JH; Heininger M; Orosz CG
    Transplantation; 2000 Dec; 70(12):1771-80. PubMed ID: 11152110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe combined immunodeficient mice engrafted with human splenocytes have functional human T cells and reject human allografts.
    Alegre ML; Peterson LJ; Jeyarajah DR; Weiser M; Bluestone JA; Thistlethwaite JR
    J Immunol; 1994 Sep; 153(6):2738-49. PubMed ID: 8077678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors.
    Christianson SW; Shultz LD; Leiter EH
    Diabetes; 1993 Jan; 42(1):44-55. PubMed ID: 8093606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of infectious tolerance after donor-specific transfusion and rat heart transplantation.
    Kataoka M; Margenthaler JA; Ku G; Flye MW
    J Immunol; 2003 Jul; 171(1):204-11. PubMed ID: 12816999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.